New Facility to Service Growing Business in Textiles, Global Supply
Chains from the Asia Pacific Region
Company Website:
http://www.adnas.com
STONY BROOK, N.Y. -- (Business Wire)
Applied
DNA Sciences, Inc. (NASDAQ:APDN, “Applied DNA,” “the Company”) today
announced the establishment of a Central DNA Testing Laboratory in
Ahmedabad, India providing full forensic authentication services. The
laboratory supports Applied DNA’s growing global textile business in the
Asia-Pacific region with expansion capability for other supply chains
present in the region, such as fertilizer and pharmaceuticals.
Officially opening on February 15, 2018, the Central Laboratory is
strategically located in the state of Gujarat, an economic hub for the
development and advancement of cotton, other textiles, fertilizers,
petrochemicals and pharmaceuticals.
Dr. Ila Lansky, a forensic scientist with over 11 years of forensic DNA
experience, will direct the Central DNA Testing Laboratory. She
currently oversees all aspects of forensic analysis, testing,
authentication and reporting for all samples submitted, following the
standard operating procedures established by Applied DNA’s New York
forensic laboratories. The Central DNA Testing Laboratory is a high
throughput laboratory, providing customers with accurate reports in a
short turnaround time.
“This is an important opportunity for Applied DNA to bring our proven
technologies to the heart of India’s textile industry, and share our
impeccable standards and operational protocols,” said Dr. Lansky. “The
laboratory will have the ability to process thousands of samples,
serving our textiles customers in the region.”
The Indian textile industry is currently estimated at approximately $135
billion USD and is expected to reach $230 billion by 2023 (IBEF 2017).
It is home to such global textile brands and manufacturers as The
Himatsingka Group and GHCL Limited. Additionally, India is home to the
sixth largest pharmaceutical market in the world, with an expected value
of $550 billion by 2020 (IBEF 2017).
“Opening a lab in Gujarat has both strategic and practical importance
for Applied DNA,” said Dr. James A. Hayward, president and chief
executive officer of Applied DNA. “Our partnership with Himatsingka has
proven remarkably successful, with uptake in the commercial ecosystem
and endorsement by big box retailers. Adoption of our technologies by
other textile companies is growing. Working closely with such
India-based industry majors as Himatsingka and GHCL, we know Applied
DNA’s value in enabling source-verified supplied chains and contributing
the steady growth and ensured protection of the circular economy. It
only makes sense for Applied DNA to have a facility where so many of our
current and future partners are based.”
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics. The
Company makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help protect
products, brands, entire supply chains, and intellectual property of
companies, governments and consumers from theft, counterfeiting, fraud
and diversion.
The proprietary DNA-based CertainT®
platform can be used to identify, tag, test, and track products, to help
assure authenticity, origin, traceability, sustainability and quality of
products. SigNature® DNA describes the core technology
ingredient that is at the heart of a family of uncopyable, security and
authentication solutions such as SigNature®T and fiberTyping®,
targeted towards textiles and apparel, BackTrac® and DNAnet®,
for anti-theft and loss prevention, and digitalDNA®,
providing powerful track-and-trace. All provide a forensic chain of
evidence, and can be used to prosecute perpetrators. Applied DNA
Sciences is also engaged in the large-scale production of specific DNA
sequences using the polymerase chain reaction.
Visit adnas.com for
more information. Follow us on Twitter and LinkedIn.
Join our mailing
list.
Forward-Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe APDN’s
future plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of
which are beyond the control of APDN. Actual results could differ
materially from those projected due to our short operating history,
limited financial resources, limited market acceptance, market
competition and various other factors detailed from time to time in
APDN’s SEC reports and filings, including our Annual Report on Form 10-K
filed on December 28, 2017, which is available at www.sec.gov.
APDN undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances after the
date hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180123005178/en/
Contacts:
Applied DNA Sciences
Investors:
Sanjay M. Hurry,
212-838-3777
shurry@lhai.com
or
Media:
Angie
Mathews, 781-639-4924
angie@cgprpublicrelations.com
or
Program:
MeiLin
Wan, 631-240-8849
meilin.wan@adnas.com
or
web: www.adnas.com
twitter:
@APDN
Source: Applied DNA Sciences, Inc.
© 2024 Canjex Publishing Ltd. All rights reserved.